TNF-α promotes colon cancer cell migration and invasion by upregulating TROP-2

Oncology Letters

Volumn 15, Issue 3, 2018, Pages 3820-3827

  Zhao, Peng ^a   Zhang, Zhongtao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Colon cancer; Metastasis; Tumor invasion; Tumor necrosis factor ; Tumor associated calcium signal transduction protein 2

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR ASSOCIATED CALCIUM SIGNAL TRANSDUCTION PROTEIN 2; TUMOR NECROSIS FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

EID: 85040829943     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2018.7735     Document Type: Article

References (22)

1. Eiró N and Vizoso FJ: Inflammation and cancer. World J Gastrointest Surg 27: 62-72, 2012.
2. Calcinotto A, Grioni M, Jachetti E, Curnis F, Mondino A, Parmiani G, Corti A and Bellone M: Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy. J Immunol 188: 2687-2694, 2012.
3. Ikemoto S, Sugimura K, Yoshida N, Wada S, Yamamoto K and Kishimoto T: TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma. Anticancer Res 20: 317-321, 2000.
4. Wu Y, Deng J, Rychahou PQ, Qiu S, Evers BM and Zhou BP: Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15: 416-428, 2009.
5. Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M, Yamada Y, et al: The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res 59: 1911-1916, 1999.
6. Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M and Laimer K: TROP2: A novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 21: 186-191, 2008.
7. Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, Gastl G and Spizzo G: High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 99: 1290-1295, 2008.
8. Mühlmann G, Spizzo G, Gostner J, Zitt M, Maier H, Moser P, Gastl G, Zitt M, Müller HM, Margreiter R, et al: TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol 62: 152-158, 2009.
9. Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, et al: Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer 46: 944-953, 2010.
10. Pak MG, Shin DH, Lee CH and Lee MK: Significance of EpCAM and TROP2 expression in non-small cell lung cancer. World J Surg Oncol 10: 53, 2012.
11. Trerotola M, Rathore S, Goel HL, Li J, Alberti S, Piantelli M, Adams D, Jiang Z and Languino LR: Trop-2 and alpha-2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am J Transl Res 2: 135-144, 2010.
12. Zhao P, Yu HZ and Cai JH: Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer. Mol Med Rep 12: 4364-4369, 2015.
13. Stepan LP, Trueblood ES, Hale K, Babcook J, Borges L and Sutherland CL: Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: Potential implications as a cancer therapeutic target. J Histochem Cytochem 59: 701-710, 2011.
14. Schnider CA, Rasband WS and Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675, 2012.
15. Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Hu J and Sun Y: BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol Lett 8: 1947-1952, 2014.
16. Colotta F, Allavena P, Sica A, Garlanda C and Mantovani A: Cancer related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 30: 1073-1081, 2009.
17. Wolczyk D, Zaremba-Czogalla M, Hryniewicz-Jankowska A, Tabola R, Grabowski K, Sikorski AF and Augoff K: TNF-α promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid rafts. Cell Oncol (Dordr) 39: 353-363, 2016.
18. Gao ZL, Yang CC, Xu XH, et al: Experimental study on TNF-α promoting invasion and metastasis of oral cancer cells by regu-lating MMPs. Stomatology 34: 9-12, 2014.
19. Hong H, Jiang L, Lin Y, He C, Zhu G, Du Q, Wang X, She F and Chen Y: TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway. BMC Cancer 16: 240, 2016.
20. Choo MK, Sakurai H, Koizumi K and Saiki I: Stimulation of cultured colon 26 cells with TNF-alpha promotes lung metastasis through the extracellular signal-regulated kinase pathway. Cancer Lett 230: 47-56, 2005.
21. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C and Balkwill FR: Macrophages induce invasiveness of epithelial cancer cells via NF-kappaB and JNK. J Immunol 175: 1197-1205, 2005.
22. Muthukumaran N, Miletti-González KE, Ravindranath AK and Rodríguez-Rodríguez L: Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells. Mol Cancer Res 4: 511-520, 2006.